CRISPR Therapeutics AG
| CIK |
Ticker |
Name |
Accession Number |
Date |
Form |
| 1674416 |
|
CRISPR Therapeutics AG |
0000950170-25-102052 |
2025-08-04 16:30:24 |
10-Q
|
| 1674416 |
|
CRISPR Therapeutics AG |
0000950170-25-102027 |
2025-08-04 16:21:40 |
8-K
|
| 1674416 |
|
CRISPR Therapeutics AG |
0000950170-25-090170 |
2025-06-26 07:08:02 |
8-K
|
| 1674416 |
|
CRISPR Therapeutics AG |
0000950170-25-083799 |
2025-06-09 16:33:09 |
8-K
|
| 1674416 |
|
CRISPR Therapeutics AG |
0000950170-25-074428 |
2025-05-19 16:36:37 |
8-K
|
| 1674416 |
|
CRISPR Therapeutics AG |
0000950170-25-045232 |
2025-03-26 16:12:47 |
8-K
|
| 1674416 |
|
CRISPR Therapeutics AG |
0000950170-24-121105 |
2024-11-05 09:10:55 |
10-Q
|
| 1674416 |
|
CRISPR Therapeutics AG |
0000950170-24-121103 |
2024-11-05 09:05:08 |
8-K
|
| 1674416 |
|
CRISPR Therapeutics AG |
0000950170-24-090746 |
2024-08-05 16:10:26 |
10-Q
|
| 1674416 |
|
CRISPR Therapeutics AG |
0000950170-24-090727 |
2024-08-05 16:05:11 |
8-K
|
| 1674416 |
|
CRISPR Therapeutics AG |
0000950170-24-067660 |
2024-06-03 08:06:56 |
8-K
|
| 1674416 |
|
CRISPR Therapeutics AG |
0000950123-24-005877 |
2024-05-23 08:14:37 |
8-K
|
| 1674416 |
|
CRISPR Therapeutics AG |
0000950170-24-055719 |
2024-05-08 16:20:38 |
10-Q
|
| 1674416 |
|
CRISPR Therapeutics AG |
0000950170-24-055689 |
2024-05-08 16:15:20 |
8-K
|
| 1674416 |
|
CRISPR Therapeutics AG |
0000950170-24-017571 |
2024-02-21 07:50:50 |
10-K
|
| 1674416 |
|
CRISPR Therapeutics AG |
0000950170-24-017568 |
2024-02-21 07:45:22 |
8-K
|
| 1674416 |
|
CRISPR Therapeutics AG |
0001193125-24-033973 |
2024-02-13 17:22:11 |
8-K
|
| 1674416 |
|
CRISPR Therapeutics AG |
0001193125-24-032825 |
2024-02-13 06:30:54 |
8-K
|
| 1674416 |
|
CRISPR Therapeutics AG |
0000950170-24-004616 |
2024-01-16 16:11:36 |
8-K
|
| 1674416 |
|
CRISPR Therapeutics AG |
0000950170-23-071505 |
2023-12-19 16:23:43 |
8-K
|
| 1674416 |
|
CRISPR Therapeutics AG |
0000950170-23-070582 |
2023-12-15 08:58:16 |
8-K
|
| 1674416 |
|
CRISPR Therapeutics AG |
0000950170-23-069892 |
2023-12-13 09:22:49 |
8-K
|
| 1674416 |
|
CRISPR Therapeutics AG |
0000950170-23-069892 |
2023-12-13 09:22:49 |
8-K
|
| 1674416 |
|
CRISPR Therapeutics AG |
0000950170-23-068974 |
2023-12-08 13:16:14 |
8-K
|
| 1674416 |
|
CRISPR Therapeutics AG |
0000950170-23-067774 |
2023-12-04 16:26:02 |
8-K
|
| 1674416 |
|
CRISPR Therapeutics AG |
0000950170-23-064341 |
2023-11-16 07:21:51 |
8-K
|
| 1674416 |
|
CRISPR Therapeutics AG |
0000950170-23-059476 |
2023-11-06 16:42:03 |
10-Q
|
| 1674416 |
|
CRISPR Therapeutics AG |
0000950170-23-059461 |
2023-11-06 16:33:33 |
8-K
|
| 1674416 |
|
CRISPR Therapeutics AG |
0000950170-23-046889 |
2023-09-07 08:39:31 |
8-K
|
| 1674416 |
|
CRISPR Therapeutics AG |
0000950170-23-039075 |
2023-08-07 16:12:38 |
10-Q
|
| 1674416 |
|
CRISPR Therapeutics AG |
0000950170-23-039057 |
2023-08-07 16:07:02 |
8-K
|
| 1674416 |
|
CRISPR Therapeutics AG |
0000950170-23-027277 |
2023-06-09 16:29:10 |
8-K
|
| 1674416 |
|
CRISPR Therapeutics AG |
0000950170-23-027129 |
2023-06-09 07:07:13 |
8-K
|
| 1674416 |
|
CRISPR Therapeutics AG |
0000950170-23-018811 |
2023-05-08 16:11:26 |
10-Q
|
| 1674416 |
|
CRISPR Therapeutics AG |
0000950170-23-018790 |
2023-05-08 16:06:06 |
8-K
|
| 1674416 |
|
CRISPR Therapeutics AG |
0000950170-23-011476 |
2023-04-03 08:10:44 |
8-K
|
| 1674416 |
|
CRISPR Therapeutics AG |
0000950170-23-010439 |
2023-03-29 08:08:58 |
8-K
|
| 1674416 |
|
CRISPR Therapeutics AG |
0000950170-23-009861 |
2023-03-27 08:08:29 |
8-K
|
| 1674416 |
|
CRISPR Therapeutics AG |
0000950170-23-007716 |
2023-03-14 08:15:50 |
8-K
|
| 1674416 |
|
CRISPR Therapeutics AG |
0000950170-23-003441 |
2023-02-21 16:11:51 |
10-K
|
| 1674416 |
|
CRISPR Therapeutics AG |
0000950170-23-003436 |
2023-02-21 16:06:36 |
8-K
|
| 1674416 |
|
CRISPR Therapeutics AG |
0000950170-22-020845 |
2022-11-01 16:12:27 |
10-Q
|
| 1674416 |
|
CRISPR Therapeutics AG |
0000950170-22-020834 |
2022-11-01 16:05:59 |
8-K
|
| 1674416 |
|
CRISPR Therapeutics AG |
0000950170-22-020257 |
2022-10-27 08:36:26 |
8-K
|
| 1674416 |
|
CRISPR Therapeutics AG |
0000950170-22-018864 |
2022-09-27 07:48:51 |
8-K
|
| 1674416 |
|
CRISPR Therapeutics AG |
0000950170-22-015256 |
2022-08-08 08:11:21 |
10-Q
|
| 1674416 |
|
CRISPR Therapeutics AG |
0000950170-22-015255 |
2022-08-08 08:05:44 |
8-K
|
| 1674416 |
|
CRISPR Therapeutics AG |
0000950170-22-011912 |
2022-06-21 17:05:13 |
8-K
|
| 1674416 |
|
CRISPR Therapeutics AG |
0000950170-22-011570 |
2022-06-13 16:58:09 |
8-K
|
| 1674416 |
|
CRISPR Therapeutics AG |
0000950170-22-011518 |
2022-06-13 08:02:42 |
8-K
|
